Evidence map›Paper›PMID 18662246›Full record

ArticleJournal of neurochemistry2008

NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture.

Anne P Sinke, Arumugam R Jayakumar, Kiran S Panickar, Mitsuaki Moriyama, Pichili V B Reddy, Michael D Norenberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκB.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Hyperammonemia in Inherited Metabolic Diseases.Cellular and molecular neurobiology · 2022
    Review
  14. Review
  15. Hepatic encephalopathy.Nature reviews. Disease primers · 2022
    Review
  16. Review
  17. Article
  18. A NovelFrontiers in bioengineering and biotechnology · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Anne P SinkeRadboud University Nijmegen, Nijmegen, The Netherlands.
Arumugam R Jayakumar
Kiran S Panickar
Mitsuaki Moriyama
Pichili V B Reddy
Michael D Norenberg
University of Miami · USOsaka Prefecture University · JPRadboud University Nijmegen · NLVeterans Health Administration · US

Funding

The Permeability Transition in Hepatic EncephalopathyR01DK063311 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI NORENBERG, MICHAEL DAVID · 2003 to 2012
$1.8M
NIDDK NIH HHS DK063311NIDDK NIH HHS R01 DK063311
6 · The paper itself

Abstract

Astrocyte swelling and brain edema are major neuropathological findings in the acute form of hepatic encephalopathy (fulminant hepatic failure), and substantial evidence supports the view that elevated brain ammonia level is an important etiological factor in this condition. Although the mechanism by which ammonia brings about astrocyte swelling remains to be determined, oxidative/nitrosative stress and mitogen-activated protein kinases (MAPKs) have been considered as important elements in this process. One factor known to be activated by both oxidative stress and MAPKs is nuclear factor kappaB (NFkappaB), a transcription factor that activates many genes, including inducible nitric oxide synthase (iNOS). As the product of iNOS, nitric oxide (NO), is known to cause astrocyte swelling, we examined the potential involvement of NFkappaB in ammonia-induced astrocyte swelling. Western blot analysis of cultured astrocytes showed a significant increase in NFkappaB nuclear translocation (a measure of NFkappaB activation) from 12 h to 2 days after treatment with NH(4)Cl (5 mM). Cultures treated with anti-oxidants, including superoxide dismutase, catalase, and vitamin E as well as the MAPKs inhibitors, SB239063 (an inhibitor of p38-MAPK) and SP600125 (an inhibitor of c-Jun N-terminal kinase), significantly diminished NFkappaB activation by ammonia, supporting a role of oxidative stress and MAPKs in NFkappaB activation. The activation of NFkappaB was associated with increased iNOS protein expression and NO generation, and these changes were blocked by BAY 11-7082, an inhibitor of NFkappaB. Additionally, ammonia-induced astrocyte swelling was inhibited by the NFkappaB inhibitors, BAY 11-7082 and SN-50, thereby implicating NFkappaB in the mechanism of astrocyte swelling. Our studies indicate that cultured astrocytes exposed to ammonia display NFkappaB activation, which is likely to be a consequence of oxidative stress and activation of MAPKs. NFkappaB activation appears to contribute to the mechanism of ammonia-induced astrocyte swelling, apparently through its up-regulation of iNOS protein expression and the subsequent generation of NO.

Indexed as

Oxidative StressActive Transport, Cell NucleusAmmoniaAnimalsAnimals, NewbornAntioxidantsAstrocytesBrain EdemaCells, CulturedCell SizeEnzyme ActivationEnzyme InhibitorsHepatic EncephalopathyMAP Kinase Signaling SystemNF-kappa BNitric OxideAmmoniaAntioxidantsEnzyme InhibitorsNF-kappa BNitric OxideNitric Oxide Synthase Type II

Identifiers

PMID18662246
PMCPMC2597622
OpenAlexW2150978365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.